Tenet Q1 adjusted EPS $4.36, +35% YoY; Adj EBITDA $1.163B, +13.6%; guides FY adj EBITDA $3.975-4.175B

TENET HEALTHCARE CORP

2025-Q1 EPS reported $4.27 revenue$5,223,000,000

Net income available to common shareholders $406M ($4.27 diluted) vs $2.151B in Q1 2024 (prior year included $2.5B divestiture gain).
Adjusted diluted EPS $4.36 vs $3.22, +35.4%; consolidated net operating revenues $5.223B (down 2.7% due to hospital divestitures).
Ambulatory Care segment Adj EBITDA $456M (+15.7%), revenue per case up 9.1%; Hospital segment Adj EBITDA $707M (+12.2%) on 4.4% same-hospital admissions growth.
Free cash flow $642M, up from $346M; repurchased 2.63M shares for $348M during Q1.
FY 2025 outlook: Adj EBITDA $3.975-$4.175B; Adj diluted EPS $11.99-$13.12; free cash flow $1.8-$2.05B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.